BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34902568)

  • 1. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.
    Singal AG; Reddy S; Radadiya Aka Patel H; Villarreal D; Khan A; Liu Y; Cerda V; Rich NE; Murphy CC; Tiro JA; Kramer JR; Hernaez R
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2818-2825.e1. PubMed ID: 34902568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.
    Singal AG; Tiro JA; Murphy CC; Marrero JA; McCallister K; Fullington H; Mejias C; Waljee AK; Pechero Bishop W; Santini NO; Halm EA
    Hepatology; 2019 Jan; 69(1):121-130. PubMed ID: 30070379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.
    Singal AG; Tiro JA; Marrero JA; McCallister K; Mejias C; Adamson B; Bishop WP; Santini NO; Halm EA
    Gastroenterology; 2017 Feb; 152(3):608-615.e4. PubMed ID: 27825963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
    Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis.
    Singal AG; Chen Y; Sridhar S; Mittal V; Fullington H; Shaik M; Waljee AK; Tiro J
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1795-1802.e2. PubMed ID: 33662594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
    Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
    JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.
    Singal AG; Tiro JA; Murphy CC; Blackwell JM; Kramer JR; Khan A; Liu Y; Zhang S; Phillips JL; Hernaez R
    Clin Gastroenterol Hepatol; 2021 May; 19(5):987-995.e1. PubMed ID: 32629122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.
    Singal AG; Patibandla S; Obi J; Fullington H; Parikh ND; Yopp AC; Marrero JA
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1925-1932.e1. PubMed ID: 32920214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
    BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort.
    Chen VL; Singal AG; Tapper EB; Parikh ND
    Liver Int; 2020 Apr; 40(4):947-955. PubMed ID: 31943689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 17. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.
    Dalton-Fitzgerald E; Tiro J; Kandunoori P; Halm EA; Yopp A; Singal AG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):791-8.e1. PubMed ID: 25019694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of mailed outreach with behavioral economic interventions to improve liver cancer surveillance.
    Mehta SJ; McDonald C; Reitz C; Kastuar S; Snider CK; Okorie E; McNelis K; Shaikh H; Cook TS; Goldberg DS; Rothstein K
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38099859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
    Singal AG; Pillai A; Tiro J
    PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.